Clinical Trials Directory

Trials / Unknown

UnknownNCT02518126

Leukemia Inhibitory Factor Level in Intrauterine Growth Restriction Neonates

Comparison of LIF (Leukemia Inhibitory Factor) Level Between Neonates Who Are IUGR (Intra Uterine Growth Restriction) and Those Who Are AGA (Average for Gestational Age)

Status
Unknown
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Rambam Health Care Campus · Academic / Other
Sex
Female
Age
16 Years – 45 Years
Healthy volunteers
Accepted

Summary

To see if there is a relationship between the level of LIF in IUGR fetuses and compared to the level of LIF in AGA fetuses

Detailed description

During embryonic development, there are several cytokines such as: LIF (Leukemia inhibitory factor), ciliary neurotrophic factor (CNTF), epidermal growth factor family (EGF), neuregulin 1 (NRG1) and transforming growth factor β (TGFβ) that were found are associated with neurogenesis and differentiation of brain cells . LIF is a cytokine that is essential for the development of the central nervous system, and has recently been shown in rats that maternal LIF stimulates placental ACTH that in turn promotes secretion of fetal LIF from nRBC , which in turn promotes brain development of the fetus Other studies on IUGR (Intra Uterine Growth Restriction) have shown that IUGR fetuses have more CP (Cerebral palsy) than those who were AGA (Average for Gestational Age) The hypothesis is that LIF is related to the proper development of the nervous system in the fetus and by testing cord blood of embryos IUGR and the placenta we will find changes in LIF and ACTH compared with AGA fetuses level. Studies have also shown a relationship between CP and IUGR, but the mechanism for this relationship is unclear. The purpose of our research is to see if there is a relationship between the level of LIF in IUGR fetuses and compared to the level of LIF in AGA fetuses, in one of two ways: * Changes in the secretion of ACTH in placenta * Changes in levels of LIF in the umbilical cord blood

Conditions

Interventions

TypeNameDescription
OTHERblood sample and tissue sampleAfter birth and fetal umbilical cord disconnection, a blood sample will be taken from the umbilical cord (cord blood) of IUGR and of AGA fetuses (5cc) for cytokine ELISA testing. Also a small sample of the placenta will be examined in order to assess the level of ACTH protein in IUGR and AGA embryos

Timeline

Start date
2015-08-01
Primary completion
2017-06-01
Completion
2017-06-01
First posted
2015-08-07
Last updated
2015-08-07

Source: ClinicalTrials.gov record NCT02518126. Inclusion in this directory is not an endorsement.